Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

Clinical trial NCT05519111 · RECRUITING

Trial details

NCT number: NCT05519111
Sponsor: Icahn School of Medicine at Mount Sinai
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2025-04-03
Primary completion: 2027-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.